Search PDMR transactions

Notifier
Name of person with notification obligation
Siavash Bashiri
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Siavash Bashiri
Position
Deputy CEO/Deputy Managing Director
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Xbrane Biopharma AB
Issuer´s LEI code
5493008DKD05APTKQO39
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Xbrane Biopharma AB SE0007789409 Acquisition 870 Quantity 80.00 SEK 12/06/2023 NASDAQ STOCKHOLM AB
Share Xbrane Biopharma AB SE0007789409 Disposal 870 Quantity 80.00 SEK 12/06/2023 NASDAQ STOCKHOLM AB
Share Xbrane Biopharma AB SE0007789409 Acquisition 9,400 Quantity 79.50 SEK 12/06/2023 NASDAQ STOCKHOLM AB
Share Xbrane Biopharma AB SE0007789409 Disposal 9,400 Quantity 79.50 SEK 12/06/2023 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Xbrane Biopharma AB SE0007789409 Acquisition 12/06/2023 NASDAQ STOCKHOLM AB 10,270 (Quantity) 79.54235638 SEK
Xbrane Biopharma AB SE0007789409 Disposal 12/06/2023 NASDAQ STOCKHOLM AB 10,270 (Quantity) 79.54235638 SEK
<< Back